# 血气和电解质分析仪市场

> 血气和电解质分析仪市场研究报告按应用（重症监护病房、急诊科、手术室、住院病房、门诊诊所）、按样本类型（动脉血、静脉血、毛细血、尿液）、按便携性（便携式分析仪、台式分析仪）、按技术（电化学传感器、光学传感器、离子选择电极）、按测量参数（血液pH、血气（PCO2、PO2）、电解质（Na+、K+、Cl-、Ca2+）、肌酐、乳酸）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.54%
- **2024:** $ 51.66 Billion
- **2025:** $ 54.52 Billion
- **2035:** $ 93.5 Billion
- **Key Players:** Abbott Laboratories (US), Roche Diagnostics (CH), Siemens Healthineers (DE), Thermo Fisher Scientific (US), F. Hoffmann-La Roche AG (CH), Becton Dickinson and Company (US), Medtronic (IE), Instrumentation Laboratory (US), Nova Biomedical (US)

**Report ID:** MRFR/HC/39415-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/blood-gas-and-electrolyte-analyzer-market-29789

---

## Market Summary

## **Blood Gas and Electrolyte Analyzer Market Overview**

As per MRFR analysis, the Blood Gas and Electrolyte Analyzer Market Size was estimated at 49.04 (USD Billion) in 2023. The Blood Gas and Electrolyte Analyzer Market Industry is expected to grow from 51.66 (USD Billion) in 2024 to 79.55 (USD Billion) by 2032. The Blood Gas and Electrolyte Analyzer Market CAGR (growth rate) is expected to be around 5.54% during the forecast period (2024 - 2032).

### **Key Blood Gas and Electrolyte Analyzer Market Trends Highlighted**

The Blood Gas and Electrolyte Analyzer Market is driven by the increasing prevalence of chronic diseases such as diabetes and renal disorders, technological advancements in analyzer design and capabilities, and rising demand for point-of-care testing.

The market is expected to witness significant growth in the coming years due to the increasing focus on early diagnosis and effective management of critical conditions. Technological advancements such as miniaturization, automation, and the integration of artificial intelligence are further enhancing the accuracy, speed, and ease of use of these analyzers.

Additionally, the trend toward personalized medicine and the growing adoption of precision healthcare are creating opportunities for the development of more specialized analyzers that cater to specific patient needs.

## **Blood Gas and Electrolyte Analyzer Market Drivers**

### Technological Innovations Driving Market Growth

Advancements in technology are propelling the growth of the Blood Gas and Electrolyte Analyzer Market Industry. The introduction of cutting-edge devices with enhanced features and capabilities is transforming the market landscape.

These innovative analyzers offer faster and more accurate results, enabling healthcare professionals to make informed decisions promptly. The integration of advanced sensors, microfluidics, and data analytics has revolutionized the field of Blood Gas and Electrolyte analysis.

These technological advancements have significantly improved patient care and facilitated the early detection and management of various health conditions. The increasing adoption of these innovative analyzers in clinical settings is expected to drive market expansion in the coming years.

### Rising Prevalence of Chronic Diseases

The growing prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and respiratory disorders, is a key factor driving the demand for Blood Gas and Electrolyte analyzers.

These conditions often require regular monitoring of blood gases and electrolytes to assess the patient's acid-base balance, hydration status, and electrolyte levels. The increasing incidence of these diseases has led to a surge in the demand for accurate and reliable analyzers that can provide timely and accurate results.

The rising burden of chronic diseases is expected to continue fueling the growth of the Blood Gas and Electrolyte Analyzer Market Industry.

### Increasing Awareness and Focus on Preventive Healthcare

Growing awareness about the importance of preventive healthcare is contributing to the expansion of the Blood Gas and Electrolyte Analyzer Market Industry. Individuals are becoming more proactive in managing their health and seeking regular check-ups and screenings.

This heightened awareness has led to an increased demand for Blood Gas and Electrolyte analysis as a part of routine health assessments. The focus on preventive healthcare has also encouraged the adoption of advanced analyzers in wellness clinics, fitness centers, and home settings. This trend is expected to further drive market growth as more people prioritize their health and well-being.

****
Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Blood Gas and Electrolyte Analyzer Market Segment Insights**

### **Blood Gas and Electrolyte Analyzer Market Application Insights**

The Application segment of the Blood Gas and Electrolyte Analyzer Market is categorized into Critical Care Units, Emergency Departments, Operating Rooms, Inpatient Wards, and Outpatient Clinics. Among these segments, Critical Care Units held the largest market share in 2023, accounting for over 35% of the Blood Gas and Electrolyte Analyzer Market revenue.

The high demand for Blood Gas and Electrolyte analyzers in critical care units can be attributed to the need for real-time monitoring of critically ill patients. Emergency Departments are expected to witness significant growth during the forecast period, owing to the increasing number of emergency cases and the need for rapid diagnosis and treatment.

Operating Rooms are another major application segment, where Blood Gas and Electrolyte analyzers are used to monitor patients during surgical procedures. Inpatient Wards and Outpatient Clinics are also expected to contribute to the growth of the Blood Gas and Electrolyte Analyzer Market, as they provide convenient and accessible testing options for patients.

The rising prevalence of chronic diseases, increasing healthcare expenditure, and technological advancements are driving the growth of the Blood Gas and Electrolyte Analyzer Market.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Blood Gas and Electrolyte Analyzer Market Sample Type Insights**

The Blood Gas and Electrolyte Analyzer Market is segmented by Sample Type into Arterial Blood, Venous Blood, Capillary Blood, and Urine. The Arterial Blood segment accounted for the largest revenue share in 2023, and it is projected to continue to dominate the market during the forecast period.

This is due to the fact that arterial blood provides the most accurate measurement of blood gases and electrolytes, as it is taken directly from an artery. The Venous Blood segment is expected to grow at the fastest CAGR during the forecast period.

This is due to the increasing use of venous blood for Blood Gas and Electrolyte analysis, as it is less invasive and more convenient than arterial blood collection. The Capillary Blood segment is expected to account for a small share of the market during the forecast period.

This is due to the fact that capillary blood provides less accurate measurements than arterial or venous blood. The Urine segment is expected to account for a small share of the market during the forecast period. This is due to the fact that urine is not as accurate as blood for measuring blood gases and electrolytes.

### **Blood Gas and Electrolyte Analyzer Market Portability Insights**

Portable analyzers are expected to account for a larger revenue share in the Blood Gas and Electrolyte Analyzer Market during the forecast period. The increasing adoption of portable analyzers in point-of-care settings, such as clinics, emergency departments, and ambulances, is driving the growth of this segment.

Portable analyzers offer several advantages over benchtop analyzers, including ease of use, portability, and rapid turnaround time for results. They are particularly useful in situations where timely and accurate results are critical, such as in critical care units and during emergencies.

Benchtop analyzers, on the other hand, are typically used in laboratory settings and offer higher throughput and automation capabilities. However, they are less portable and require more space and infrastructure.

### **Blood Gas and Electrolyte Analyzer Market Technology Insights**

The Blood Gas and Electrolyte Analyzer Market is segmented by technology into electrochemical sensors, optical sensors, and ion-selective electrodes. Electrochemical sensors held the largest market share in 2023 and are expected to continue to dominate the market through 2032. This is due to their high accuracy and precision, as well as their ability to measure a wide range of analytes.

Optical sensors are expected to grow at the fastest rate during the forecast period, due to their non-invasive nature and their ability to provide real-time monitoring.

Ion-selective electrodes are expected to remain a niche market but are still expected to see some growth due to their low cost and simplicity. In 2023, the Blood Gas and Electrolyte Analyzer Market was valued at USD 2.96 billion.

The growth of the market is being driven by the increasing demand for Blood Gas and Electrolyte analysis in various healthcae settings, such as hospitals, clinics, and laboratories.

### **Blood Gas and Electrolyte Analyzer Market Parameters Measured Insights**

The Parameters Measured segment of the Blood Gas and Electrolyte Analyzer Market is segmented into Blood pH, Blood Gases (PCO2, PO2), Electrolytes (Na+, K+, Cl-, Ca2+), Creatinine, and Lactate.

Among these, the Blood Gases sub-segment is expected to hold the largest market share in 2023, owing to the increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD) and asthma, which require frequent monitoring of blood gas levels. The Electrolytes sub-segment is also expected to witness significant growth during the forecast period, driven by the rising incidence of electrolyte imbalances due to dehydration, kidney disease, and other medical conditions.

The Blood Gas and Electrolyte Analyzer Market revenue for the Parameters Measured segment is projected to reach USD 1.5 billion by 2024, growing at a CAGR of 5.2% during the forecast period.

This growth is attributed to the increasing adoption of advanced Blood Gas and Electrolyte analyzers in hospitals, clinics, and laboratories, as well as the rising awareness about the importance of regular Blood Gas and Electrolyte monitoring for early diagnosis and management of various health conditions.

### **Blood Gas and Electrolyte Analyzer Market Regional Insights**

The Blood Gas and Electrolyte Analyzer Market is segmented into North America, Europe, APAC, South America, and MEA. Among these regions, North America held the largest market share in 2023 and is expected to continue its dominance throughout the forecast period.

The growth in this region can be attributed to the presence of a large number of hospitals and clinics, as well as the increasing adoption of advanced healthcare technologies. Europe and APAC are also expected to witness significant growth in the Blood Gas and Electrolyte Analyzer Market due to the rising prevalence of chronic diseases and the growing demand for point-of-care testing.

South America and MEA are expected to grow at a moderate pace, owing to the increasing healthcare expenditure and the rising awareness of the benefits of Blood Gas and Electrolyte analysis.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Blood Gas and Electrolyte Analyzer Market Key Players And Competitive Insights**

Major players in the Blood Gas and Electrolyte Analyzer Market industry are constantly striving to gain a competitive edge by investing in research and development, introducing innovative products, and expanding their geographical presence.

Leading Blood Gas and Electrolyte Analyzer Market players are focusing on developing portable and user-friendly devices, as well as those that can measure a wider range of analytes. They are also collaborating with healthcare providers and laboratories to enhance their offerings and cater to the specific needs of different end-users.

Additionally, Blood Gas and Electrolyte Analyzer Market development is being driven by technological advancements such as the integration of artificial intelligence (AI) and cloud computing, which enable real-time data analysis and remote monitoring.

Merger and acquisition activity is also expected to shape the Blood Gas and Electrolyte Analyzer Market Competitive Landscape as companies seek to expand their portfolios and gain market share.

Roche Diagnostics, a leading player in the Blood Gas and Electrolyte Analyzer Market, is known for its innovative and high-quality products. The company offers a wide range of Blood Gas and Electrolyte analyzers, including the Cobas b 123 POC analyzer, which is designed for point-of-care testing.

Roche Diagnostics has a strong presence and is committed to providing comprehensive solutions to meet the needs of healthcare professionals and patients worldwide.

Another major competitor in the Blood Gas and Electrolyte Analyzer Market is Siemens Healthineers. The company's Blood Gas and Electrolyte analyzers are used in a variety of clinical settings, including hospitals, clinics, and laboratories.

Siemens Healthineers focuses on developing innovative and user-friendly devices that can provide accurate and reliable results. The company is also committed to providing excellent customer service and support.

### **Key Companies in the Blood Gas and Electrolyte Analyzer Market Include**

## Blood Gas And Electrolyte Analyzer Market Industry Developments

- **Q2 2024: Abbott launches next-generation i-STAT Alinity blood gas analyzer** Abbott announced the launch of its new i-STAT Alinity blood gas analyzer, designed to deliver rapid, lab-quality results at the point of care, expanding its diagnostic portfolio for critical care settings.
- **Q1 2024: Radiometer receives CE mark for ABL90 FLEX PLUS blood gas analyzer** Radiometer announced that its ABL90 FLEX PLUS blood gas analyzer received CE mark approval, allowing the device to be marketed and sold in the European Union for rapid blood gas and electrolyte testing.
- **Q2 2024: Siemens Healthineers launches RAPIDPoint 500e Blood Gas System in Japan** Siemens Healthineers announced the launch of its RAPIDPoint 500e Blood Gas System in Japan, expanding its presence in the Asia-Pacific diagnostics market.
- **Q2 2024: Nova Biomedical opens new manufacturing facility in Waltham, Massachusetts** Nova Biomedical announced the opening of a new manufacturing facility in Waltham, Massachusetts, to increase production capacity for its blood gas and electrolyte analyzers.
- **Q1 2024: Medica Corporation announces FDA 510(k) clearance for EasyStat blood gas analyzer** Medica Corporation received FDA 510(k) clearance for its EasyStat blood gas analyzer, enabling commercial distribution in the United States.
- **Q3 2024: Abbott to acquire point-of-care diagnostics firm for $450 million** Abbott announced an agreement to acquire a point-of-care diagnostics company specializing in blood gas and electrolyte analyzers for $450 million, aiming to strengthen its critical care diagnostics portfolio.
- **Q2 2024: Startup draws $30M Series B to develop portable blood gas analyzer** A medical device startup developing a portable blood gas and electrolyte analyzer raised $30 million in Series B funding to accelerate product development and regulatory submissions.
- **Q1 2025: Radiometer partners with major European hospital network for blood gas analyzer deployment** Radiometer announced a partnership with a leading European hospital network to deploy its latest blood gas and electrolyte analyzers across multiple facilities.
- **Q2 2025: Siemens Healthineers receives Health Canada approval for RAPIDPoint 500e Blood Gas System** Siemens Healthineers received Health Canada approval for its RAPIDPoint 500e Blood Gas System, enabling sales and distribution in the Canadian market.
- **Q2 2025: Nova Biomedical launches Stat Profile Prime Plus blood gas analyzer in India** Nova Biomedical announced the launch of its Stat Profile Prime Plus blood gas analyzer in India, expanding its global reach in emerging markets.
- **Q1 2025: Medica Corporation appoints new CEO to drive global expansion** Medica Corporation announced the appointment of a new Chief Executive Officer, with a mandate to accelerate international growth and product innovation in the blood gas and electrolyte analyzer sector.
- **Q3 2024: Siemens Healthineers secures multi-year contract with US hospital group for blood gas analyzers** Siemens Healthineers signed a multi-year contract with a major US hospital group to supply blood gas and electrolyte analyzers, strengthening its position in the North American diagnostics market.

## **Blood Gas and Electrolyte Analyzer Market Segmentation Insights**

### **Blood Gas and Electrolyte Analyzer Market Application Outlook**

### **Blood Gas and Electrolyte Analyzer Market Sample Type Outlook**

### **Blood Gas and Electrolyte Analyzer Market Portability Outlook**

### **Blood Gas and Electrolyte Analyzer Market Technology Outlook**

### **Blood Gas and Electrolyte Analyzer Market Parameters Measured Outlook**

### **Blood Gas and Electrolyte Analyzer Market Regional Outlook**

## Market Drivers

### 关注慢性病管理

血气和电解质分析仪市场越来越与慢性病管理的重点相一致。随着糖尿病和心血管疾病等慢性病的患病率上升，定期监测血气和电解质的需求变得至关重要。医疗服务提供者认识到这些分析仪在管理患者健康方面的重要性，预计市场在未来几年将增长约6%。监测患者的电解质水平和酸碱平衡对于预防与慢性病相关的并发症至关重要。这一趋势促使制造商创新并增强其产品供应，以确保满足医疗专业人员在血气和电解质分析仪市场上不断变化的需求。

### 对即时检测的需求上升

血气和电解质分析仪市场正在经历对即时检测解决方案的显著需求增长。这一趋势主要归因于在危重护理环境中对快速诊断结果的需求，在这些环境中，及时决策至关重要。即时检测仪器能够进行即时测试，使医疗专业人员能够毫不延迟地做出明智的决策。预计即时检测市场将显著扩展，估计年增长率约为8%。这一向去中心化检测的转变正在重塑血气和电解质分析仪市场的格局，因为医院和诊所寻求通过更快的诊断来改善患者的治疗结果。因此，制造商正专注于开发用户友好、便携的设备，以满足这一日益增长的需求。

### 日益增长的预防医疗意识

血气和电解质分析仪市场正在经历增长，这一增长是由于人们对预防性医疗的意识不断提高。随着个人对健康的关注度增加，定期健康检查和监测重要参数的需求也在上升。这一趋势导致在常规筛查中对血气和电解质分析仪的使用更加重视。市场分析师预测，未来几年市场将以约7%的速度增长，医疗服务提供者将通过将这些分析仪整合到其服务中来响应这一需求。对预防性医疗的关注正在重塑血气和电解质分析仪市场，鼓励制造商开发更易获取和高效的检测解决方案。

### 增加对医疗基础设施的投资

血气和电解质分析仪市场受益于各地区对医疗基础设施的不断投资。各国政府和私营实体正在分配大量资源以增强实验室能力和改善诊断服务。这种投资在新兴市场中尤为明显，新医疗设施的建立正在增加。因此，先进的血气和电解质分析仪的需求预计将增长，市场扩张的预测显示年增长率约为5%。增强的医疗基础设施不仅促进了对诊断服务的更好获取，还鼓励了血气和电解质分析仪市场中创新技术的采用，最终改善了患者护理。

### 血气和电解质分析仪的技术进步

血气和电解质分析仪市场正在经历技术进步的激增，这些进步提高了诊断过程的准确性和效率。设备的小型化和人工智能的集成等创新正在简化临床环境中的操作。例如，便携式分析仪的引入使得在紧急情况下能够快速测试，显著缩短了周转时间。此外，传感器技术的进步提高了电解质测量的精确度，这对患者管理至关重要。预计市场在未来几年将以约7%的复合年增长率增长，这一增长受到这些技术创新的推动。随着医疗服务提供者越来越多地采用这些先进系统，血气和电解质分析仪市场可能会见证显著增长。

## Future Outlook

血气和电解质分析仪市场预计将在2024年至2035年间以5.54%的年均增长率增长，推动因素包括技术进步、对即时检测需求的增加以及慢性疾病患病率的上升。

**New opportunities:**

- 便携式分析仪的远程诊断开发

到2035年，市场预计将实现强劲增长，确立其在诊断创新领域的领导地位。

## Segment Insights

### 按应用：重症监护单位（最大）与急诊科（增长最快）

血气和电解质分析仪市场在各个应用细分领域显示出显著的分布，其中重症监护单位占据了最大的市场份额。该细分市场的突出地位源于对快速和准确诊断在危急健康情况下的高需求。紧随其后的是急诊科，由于患者数量的增加和对快速结果以指导即时临床决策的需求，这些分析仪的采用速度正在迅速提升。

在增长趋势方面，急诊科目前是市场上增长最快的领域。这一激增得益于技术的进步，导致便携式和用户友好的分析仪的开发。此外，急救医疗情况的频率增加，加上对改善患者结果的持续推动，正在推动该细分市场对增强诊断工具的需求。

重症监护病房：主导与门诊诊所：新兴

重症监护病房目前是血气和电解质分析仪市场的主导细分市场，其特点是对高精度诊断工具的需求，以管理危重病人。这些单位受益于先进分析仪的存在，这些分析仪能够快速测试，这对及时的医疗干预至关重要。相比之下，门诊诊所代表了一个新兴细分市场，受到即时检测趋势上升和对预防性医疗日益重视的推动。虽然它们正在迅速采用分析仪技术进行常规检查，但进行的测试总量仍低于重症监护环境。这一格局表明，随着门诊设施增强其诊断能力，市场机会正在扩大。

### 按样本类型：动脉血（最大）与静脉血（增长最快）

血气和电解质分析仪市场展示了多样的样本类型，其中动脉血因其在诊断呼吸和代谢疾病中的关键作用而占据最大的市场份额。静脉血紧随其后，因其在常规临床诊断中的更广泛应用而受到关注。毛细血和尿液检测占据剩余份额，满足特定患者人群和检测情况的需求。这些样本的多样化使用增强了整体市场的吸引力和在各种临床环境中的适应性。

样本类型细分中的增长趋势显示，静脉血分析的需求显著增加。分析仪能力的技术进步使得结果更快、更准确，从而推动了其快速增长。与此同时，动脉血仍然是必不可少的，尽管在新兴的静脉样本偏好下略显逊色。慢性疾病的日益普遍需要扩展可靠的检测方法，从而推动整体市场动态。

动脉血（主导）与尿液（新兴）

动脉血液分析在血气和电解质分析仪市场中占据着基石地位，特别是在重症监护环境中的重要性。它为酸中毒和碱中毒等病症提供快速可靠的诊断，使其成为主导力量。相比之下，尿液检测作为一个重要细分市场正在崛起，受益于其非侵入性特征以及在监测肾功能和电解质平衡方面的应用不断扩展。随着临床需求的演变，这两个细分市场都在不断改进；动脉检测在压力下持续创新，而尿液分析仪则受益于分析技术的进步。这两种样本类型之间的动态互动突显了它们在塑造未来患者诊断中的各自角色。

### 按可移植性：便携式分析仪（最大）与台式分析仪（增长最快）

在血气和电解质分析仪市场中，便携式分析仪目前占据最大的市场份额，主要得益于其适应性和用户友好的特点。这些设备在急救环境和床边检测中受到青睐，提供快速结果并改善患者的治疗效果。相反，台式分析仪虽然市场份额较小，但由于其先进的功能和在高容量检测环境中的效率，正在获得关注。随着实验室寻求可靠和精确的分析选项以应对复杂的检测程序，它们的增长尤为显著。

便携式细分市场的增长趋势突显了技术进步和对即时诊断解决方案日益增长的需求所驱动的重大创新和扩展。便携式分析仪在关键医疗环境中变得不可或缺，强化了快速和准确的血气分析的必要性。另一方面，台式分析仪因其稳健性和效率而越来越受到认可，制造商专注于增强其能力，以满足临床实验室对高通量检测日益增长的需求。

便携式分析仪（主导）与台式分析仪（新兴）

便携式分析仪以其紧凑的设计和易用性主导着血气和电解质分析仪市场。它们在速度和移动性至关重要的环境中尤为宝贵，例如急诊室和门诊护理环境。它们能够提供即时结果，使其不可或缺，推动了医疗专业人员的偏好。另一方面，台式分析仪代表了一个新兴细分市场，专注于更高容量的测试，具有更高的准确性和效率。随着实验室扩展其测试能力，这些分析仪变得越来越有吸引力。随着技术的持续创新以及对更高速度和准确性指标的重视，台式分析仪正在争夺更大的市场份额。

### 按技术分类：电化学传感器（最大）与光学传感器（增长最快）

在血气和电解质分析仪市场中，技术细分市场主要由电化学传感器主导，后者占据了最大的市场份额。这些传感器在提供准确的血气分析方面至关重要，并因其可靠性和易用性而广泛应用于各种医疗保健环境。同时，光学传感器虽然目前占有较小的市场份额，但在医疗服务提供者中迅速获得关注，这得益于诊断技术的进步以及在临床环境中的日益接受。
技术细分市场的增长趋势表明，分析方法正向更复杂的方向转变，光学传感器正成为市场上增长最快的细分领域。这一快速增长可归因于研发投资的增加、慢性疾病患病率的上升以及对更精确和快速诊断工具的整体推动。传感器技术的持续演变也在增强其在不同医学领域的适用性，进一步推动了市场的扩展。

技术：电化学传感器（主导）与光学传感器（新兴）

电化学传感器是血气和电解质分析仪市场的支柱，以其高精度和成本效益而闻名。它们通过电化学反应测量各种血液成分的浓度，使其在急救和危急情况下不可或缺。它们的主导地位得益于其已建立的性能历史、在各种环境中的可靠性以及与现有分析设备的广泛兼容性。另一方面，光学传感器被视为新兴技术，利用基于光的测量来增强灵敏度和特异性。虽然目前尚未像电化学传感器那样普遍，但它们提供快速和精确结果的能力使其在新兴医疗设施和创新诊断应用中越来越受欢迎。随着市场的发展，预计这一领域将扩大，以纳入先进技术，反映出向更高效和复杂的诊断工具的转变。

### 按测量参数：血气（PCO2，PO2）（最大）与电解质（Na+，K+，Cl-，Ca2+）（增长最快）

在血气和电解质分析仪市场中，市场份额在各个细分值之间的分布突显出血气，特别是PCO2和PO2，由于其在评估呼吸功能和酸碱平衡中的关键作用，占据了重要部分。相反，电解质细分市场，包括钠离子（Na+）、钾离子（K+）、氯离子（Cl-）和钙离子（Ca2+），显示出显著增长，特别是受到慢性疾病日益普遍和对即时检测日益重视的推动。

血气（主导）与电解质（新兴）

血气分析，包括PCO2和PO2等参数，被认为是市场的主导领域，因为它们提供了评估呼吸和代谢状态的基本数据。由于重症监护和急救医学的进步，其持续的需求得到了推动。相比之下，电解质领域作为一个新兴领域正在获得关注，越来越多地关注快速诊断。电解质平衡在心脏病和脱水等各种临床条件中的重要性，导致了对电解质检测在即时护理环境中的认识和采用的提高，最终推动了市场的增长。

## Regional Market Share Analysis

血气和电解质分析仪市场分为北美、欧洲、亚太地区、南美和中东及非洲。在这些地区中，北美在2023年占据了最大的市场份额，并预计将在整个预测期内继续保持主导地位。

该地区的增长可归因于大量医院和诊所的存在，以及先进医疗技术的日益普及。由于慢性疾病的发病率上升和对即时检测需求的增加，欧洲和亚太地区也预计将在血气和电解质分析仪市场中见证显著增长。

南美和中东及非洲预计将以适度的速度增长，这得益于医疗支出的增加和对血气和电解质分析益处的日益认识。

## Competitive Benchmarking

血气和电解质分析仪市场的主要参与者不断努力通过投资研发、推出创新产品和扩大地理覆盖范围来获得竞争优势。

领先的血气和电解质分析仪市场参与者专注于开发便携式和用户友好的设备，以及能够测量更广泛分析物的设备。他们还与医疗服务提供者和实验室合作，以增强他们的产品并满足不同终端用户的特定需求。

此外，血气和电解质分析仪市场的发展受到技术进步的推动，例如人工智能（AI）和云计算的整合，这使得实时数据分析和远程监控成为可能。

并购活动也预计将塑造血气和电解质分析仪市场的竞争格局，因为公司寻求扩大其产品组合并获得市场份额。

罗氏诊断是血气和电解质分析仪市场的领先参与者，以其创新和高质量的产品而闻名。该公司提供多种血气和电解质分析仪，包括Cobas b 123 POC分析仪，专为床边检测而设计。

罗氏诊断在市场上具有强大的存在感，并致力于提供全面的解决方案，以满足全球医疗专业人员和患者的需求。

血气和电解质分析仪市场的另一大竞争对手是西门子医疗。该公司的血气和电解质分析仪在医院、诊所和实验室等多种临床环境中使用。

西门子医疗专注于开发创新和用户友好的设备，能够提供准确和可靠的结果。该公司还致力于提供优质的客户服务和支持。

## Recent News & Developments

- **2024年第二季度：雅培推出下一代i-STAT Alinity血气分析仪** 雅培宣布推出其新款i-STAT Alinity血气分析仪，旨在提供快速、实验室质量的结果，扩展其在危重护理环境中的诊断产品组合。
- **2024年第一季度：Radiometer获得ABL90 FLEX PLUS血气分析仪的CE标志** Radiometer宣布其ABL90 FLEX PLUS血气分析仪获得CE标志批准，允许该设备在欧盟市场上进行快速血气和电解质测试的销售。
- **2024年第二季度：西门子医疗在日本推出RAPIDPoint 500e血气系统** 西门子医疗宣布在日本推出其RAPIDPoint 500e血气系统，扩大其在亚太地区诊断市场的影响力。
- **2024年第二季度：Nova Biomedical在马萨诸塞州沃尔瑟姆开设新制造设施** Nova Biomedical宣布在马萨诸塞州沃尔瑟姆开设新制造设施，以增加其血气和电解质分析仪的生产能力。
- **2024年第一季度：Medica Corporation宣布EasyStat血气分析仪获得FDA 510(k)批准** Medica Corporation获得FDA 510(k)批准，允许其EasyStat血气分析仪在美国进行商业分销。
- **2024年第三季度：雅培以4.5亿美元收购一家即时诊断公司** 雅培宣布达成协议，以4.5亿美元收购一家专注于血气和电解质分析仪的即时诊断公司，旨在增强其危重护理诊断产品组合。
- **2024年第二季度：初创公司获得3000万美元B轮融资以开发便携式血气分析仪** 一家开发便携式血气和电解质分析仪的医疗设备初创公司获得3000万美元B轮融资，以加速产品开发和监管申请。
- **2025年第一季度：Radiometer与一家主要欧洲医院网络合作部署血气分析仪** Radiometer宣布与一家领先的欧洲医院网络建立合作关系，在多个设施中部署其最新的血气和电解质分析仪。
- **2025年第二季度：西门子医疗获得加拿大卫生部对RAPIDPoint 500e血气系统的批准** 西门子医疗获得加拿大卫生部对其RAPIDPoint 500e血气系统的批准，允许在加拿大市场进行销售和分销。
- **2025年第二季度：Nova Biomedical在印度推出Stat Profile Prime Plus血气分析仪** Nova Biomedical宣布在印度推出其Stat Profile Prime Plus血气分析仪，扩大其在新兴市场的全球影响力。
- **2025年第一季度：Medica Corporation任命新首席执行官以推动全球扩张** Medica Corporation宣布任命新首席执行官，负责加速国际增长和血气及电解质分析仪领域的产品创新。
- **2024年第三季度：西门子医疗与美国医院集团签署多年合同供应血气分析仪** 西门子医疗与一家主要美国医院集团签署多年合同，供应血气和电解质分析仪，巩固其在北美诊断市场的地位。

## Report Scope

| 2024年市场规模 | 516.6（十亿美元） |
| --- | --- |
| 2025年市场规模 | 545.2（十亿美元） |
| 2035年市场规模 | 935（十亿美元） |
| 复合年增长率（CAGR） | 5.54%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 十亿美元 |
| 关键公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 关键市场机会 | 先进人工智能在血气和电解质分析仪市场的整合提高了诊断的准确性和效率。 |
| 关键市场动态 | 技术进步和监管变化推动血气和电解质分析仪市场的创新和竞争。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 到2035年，血气和电解质分析仪市场的预计市场估值是多少？**
A: 血气和电解质分析仪市场预计到2035年将达到935亿美元的估值。

**Q: 2024年血气和电解质分析仪市场的市场估值是多少？**
A: 在2024年，血气和电解质分析仪市场的市场估值为516.6亿美元。

**Q: 在2025年至2035年的预测期内，血气和电解质分析仪市场的预期CAGR是多少？**
A: 在2025年至2035年的预测期内，血气和电解质分析仪市场的预期CAGR为5.54%。

**Q: 在血气和电解质分析仪市场中，哪些公司被视为关键参与者？**
A: 市场上的主要参与者包括雅培实验室、罗氏诊断、西门子医疗和赛默飞世尔科技。

**Q: 在2024年，血气和电解质分析仪市场中哪个细分市场的估值最高？**
A: 在2024年，估值最高的细分市场是住院病房，估值为110亿美元。

**Q: 到2035年，便携式分析仪部门预计将增长多少？**
A: 便携式分析仪市场预计将从2024年的205亿美元增长到2035年的365亿美元。

**Q: 到2035年，血气和电解质分析仪市场中静脉血的预计值是多少？**
A: 预计到2035年，静脉血在市场上的价值将从2024年的155亿美元增加到270亿美元。

**Q: 在血气和电解质分析仪市场中，预计哪个技术领域将实现显著增长？**
A: 电化学传感器部门预计将从2024年的205亿美元增长到2035年的365亿美元。

**Q: 到2035年，电解质参数的预计值是多少？**
A: 预计电解质参数的价值将从2024年的200亿美元上升到2035年的350亿美元。

**Q: 2024年门诊诊所市场与其他细分市场相比如何？**
A: 在2024年，门诊诊所部门的估值为125.8亿美元，显示出与其他部门相比的强劲地位。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/blood-gas-and-electrolyte-analyzer-market-29789*